Predicting diabetes mellitus type 2 (T2D) incidence and prevalence across differing ethnicities.
Roche CEO outlines new R&D strategy after years of late-stage trial failures
New Roche CEO Thomas Schinecker is implementing a refined R&D strategy for the sprawling Swiss conglomerate in the wake of several recent late-stage failures. The